Go deeper into the evidence.

Available now: free profiles, glossary, study packs, learning resources and two-compound comparison. Open free tools.
Planned: Pro membership and expanded research features. Pricing and benefits shown below describe the planned offering; paid membership is not available yet. Join the free Brief to hear when it opens.

Start with the free monthly Brief. Pro is planned, not yet open. All current public learning resources and research tools remain free.

Questions

When does Pro open, and can I cancel any time?

Pro opens soon; Brief subscribers get early access. When it launches, it will be billed monthly and you will be able to cancel at any time, keeping access until the end of the billing period.

Is any of this medical advice?

No. VALREXA is an educational reference. We summarize published research and regulatory records; we never recommend treatments, doses or sources.

Who writes the content?

VALREXA is led by co-founders Elier Hernandez Gener and Miriela Fernandez, CMA. Content is prepared with source research and AI-assisted editorial tools. VALREXA does not currently have a scientific advisory board, and editorial credits are not a claim of independent expert review. Our editorial standards explain sources, review limitations and corrections; see our current review status.

Do you offer classroom or institutional access?

Instructors can use free public resources and self-service study packs, or ask about syllabus-based customization subject to confirmed availability and scope. We do not offer ongoing semester-long support. Paid institutional subscriptions are not available. See VALREXA for educators.

Do sponsors influence what you publish?

No. Sponsors and affiliates never review or edit our content. See how we make money.

Go deeper into the evidence.

Monthly newsletter

VALREXA Pro

Questions